Background & Aims: Immune responses to innocuous intestinal antigens appear tightly
Introduction
During development of T and B lymphocytes in primary lymphoid organs the genes encoding their antigen-receptors undergo random somatic rearrangements. The resulting, still immature repertoire is therefore very large and contains many cells specific for self-antigens. Probably the majority of these potentially self-reactive cells are negatively selected by induction of anergy or apoptosis 1, 2 . However, a significant number of potentially self-reactive lymphocytes leave the primary lymphoid organs and are kept under control by "peripheral tolerance mechanisms" 3 . Probably the most important of these mechanisms is assured by regulatory T lymphocytes capable of suppressing adaptive and also innate immune-responses 4, 5 .
Regulatory T cells are known to control immune responses to self-antigens (e.g. those leading
to autoimmune disease or eliminating transformed cells [4] [5] [6] ) but also to nonself-antigens (e.g.
during pregnancy or upon infection 7, 8 ). These cells are also known to control immune responses to innocuous (probably non-self) antigens in intestinal mucosa and, in experimental animal models, their absence can lead to inflammatory bowel disease (IBD) 9 . Moreover, patients with IBD appear to have defects in lamina propria regulatory T cell function 10 .
A large number of murine models for IBD have been developed allowing for a dissection of cellular and molecular mechanisms involved in this disease 11 . In the most extensively used . Another CD4 + regulatory T cell population capable of preventing IBD in mice has also been described 15 CD8 + T cells with immunosuppressive capacity also appear to play a role in oral tolerance 19 .
Another CD8 + regulatory T cell population in the mouse is characterized by high-level expression of CD122, the IL-2 receptor β-chain 20, 21 . Other naturally occurring and experimentally induced murine and human CD8 + regulatory T cell populations have also been described [22] [23] [24] [25] [26] [27] . Therefore, several naturally occurring as well as induced immunoregulatory 
Material and Methods

Mice
All mice (females) were used at 6 to 10 weeks of age, except where indicated differently.
C57BL/6 and DBA/2 mice were purchased from Janvier (Le Genest St Isle, France). RAG-2 deficient and MHC-deficient (IAβ°β2m°) C57BL/6 mice were bred in our SPF animal facility and were originally obtained from the CDTA CNRS (Orléans, France). IL-10 deficient C57BL/6 mice were purchased from Charles-River (L'Arbresle, France 
Flow cytometry analysis
The following reagents were purchased from eBiosciences (San Diego, CA): FITC- 
Intracellular IFN-γ and IL-10 detection
Cells from indicated cultures were re-stimulated with PMA (50ng/mL) and ionomycine (1µg/mL)(both from Sigma) for 4h at 37°C, Brefeldin A was added during the last 2h
(10µg/mL Sigma). Cells were subsequently stained for indicated surface-markers, fixed with 2% paraformaldehyde for 15min at 4°C, permeabilized with 0.5% saponin, 1% BSA in PBS for 30min at RT, and finally incubated for 30min at RT with FITC-conjugated anti IFN-γ or APC-conjugated anti IL-10 in permeabilization buffer. T cell-reconstituted RAG-2 deficient mice were weighed weekly and euthanized after six weeks. A 1cm piece of the distal colon was removed and fixed in 10% buffered formol.
Paraffin-embedded sections (5µm) were cut and stained with hematoxylin and eosin and used for microscopic assessment of colitis. Colons were graded semiquantitatively "no", "minor", "moderate", or "severe" colitis in a blinded fashion. In vitro suppression by CD8 (Fig. 5a ). Histological analysis of the colons of these mice 6 weeks after transfer showed no difference between mice injected with colitogenic cells alone or in combination with IL-10 deficient CD8 + CD28 -regulatory T cells (Fig. 5b) . Clinical grading of colitis in these mice confirmed that IL-10 deficient CD8 + CD28 -cells did not protect against experimental IBD (Fig. 5c) . We conclude therefore that IL-10 production by CD8 (Fig. 6 ). Co-injection of wildtype CD8 + CD28 -T cells failed to reduce weight-loss (Fig. 6a) Several naturally occurring and induced CD8 + regulatory T cell populations producing IL-10 have been identified 17, 21, 27 . Therefore, most but not all CD8 + regulatory T cell-populations appear to produce IL-10. It was therefore hypothesized that regulatory T cells may induce production of this cytokine by other cells 14 . In contrast, regulatory T cells from TGF-β1 deficient mice did not inhibit colitis in another report 41 . Moreover, LAP + but not LAP -CD4 + T cells prevented colitis 41 .
Given these contradictory reports on TGF-β in CD4 + regulatory T cell-based prevention of colitis, it will be important to evaluate the precise mechanisms involved in the TGF-β . However, it has also been described that TGF-β is required for in vitro suppression of T cell activation by CD4 + CD25 + regulatory T cells 45 . Similar to our results, in vitro inhibition of T cell activation by mouse CD122 high or human DC2-induced CD8 + regulatory T cells did not require TGF-β 21, 26 . In contrast, less well defined CD8 + regulatory T cells functioning in a TGF-β dependent manner in vitro have previously been reported [46] [47] [48] . Therefore, distinct CD8 
